<p>(<b>A</b>) Growth-quiescent SMCs were stimulated with IL-1beta (10 ng/ml) for the indicated times. Total protein extracts were resolved by SDS-PAGE and subjected to Western blot analysis using antibodies for Egr-1, EGFR phospho-Tyr<sup>845</sup>, total EGFR and beta-actin. Alternatively, Western blotting for EGFR phospho-Tyr<sup>845</sup> or EGFR of total extracts of SMCs treated with (<b>B</b>) AG1478 (5 µM), (<b>C</b>) GM6001+ or GM6001- (25 µM) (<b>D</b>) TAPI-1 (10 µM), PD153035 (5 µM) for 30 min followed by IL-1beta stimulation for 5 min.</p
<p>Undifferentiated K5<sup>+</sup>K19<sup>-</sup> hMECs were starved of serum/growth factors for 48 ...
<p>(<b>A</b>) A431 cells were treated with various concentration of LY294002 as indicated for 1 h an...
<p><b>A</b> Analysis of the total phosphorylation of EGFR. MDA-MB-468 cells were treated with 3 nM, ...
<p>Growth-quiescent SMCs were incubated with EGFR inhibitors AG1478 (5 µM) and PD153035 (5 µM) for 3...
<p>Growth-quiescent SMCs were treated with MMP inhibitor GM6001+ (25 µM) and TAPI-1 (10 µM) for 30 m...
<p>All results were normalized to the result obtained for GM conditions. <b>A</b>. Myoblasts were ly...
<p>(A) Control A-10 SMCs, or cells expressing WT or 247R receptors were cultured for 48h in 0.5% FBS...
<p>(A) BEAS-2B cells were pretreated for 30 minutes with the specific EGFR inhibitor AG 1478 and the...
<p>(<b>A</b>) A431 cells were treated with 50 ng/ml EGF for a period of time (1∼9 h) before the extr...
<p>(<b>A and B</b>) A431 cells were treated with 50 ng/ml EGF for 3 h and then treated with 5 µg/ml ...
<p>(A) SMMC7721 cells were transfected with HA-TBC1D3, HA-TBC1D3(Δ320–353) and control HA vector, re...
<p>(A) Cells were treated with PBS, DMSO (100 nM), or AG1478 (100 nM) at 37°C for 48 h. The culture ...
<p>(A,C) A-10 cells stably expressing control plasmid, WT or 247R receptors were cultured in the pre...
<p>A. CHO cells stably expressing αPIX<sup>WT</sup> or CAT (control) were transfected with EGFR expr...
<p>(A) Activation of SphK2 in response to RS218 did not differ between HBMEC with and without gefiti...
<p>Undifferentiated K5<sup>+</sup>K19<sup>-</sup> hMECs were starved of serum/growth factors for 48 ...
<p>(<b>A</b>) A431 cells were treated with various concentration of LY294002 as indicated for 1 h an...
<p><b>A</b> Analysis of the total phosphorylation of EGFR. MDA-MB-468 cells were treated with 3 nM, ...
<p>Growth-quiescent SMCs were incubated with EGFR inhibitors AG1478 (5 µM) and PD153035 (5 µM) for 3...
<p>Growth-quiescent SMCs were treated with MMP inhibitor GM6001+ (25 µM) and TAPI-1 (10 µM) for 30 m...
<p>All results were normalized to the result obtained for GM conditions. <b>A</b>. Myoblasts were ly...
<p>(A) Control A-10 SMCs, or cells expressing WT or 247R receptors were cultured for 48h in 0.5% FBS...
<p>(A) BEAS-2B cells were pretreated for 30 minutes with the specific EGFR inhibitor AG 1478 and the...
<p>(<b>A</b>) A431 cells were treated with 50 ng/ml EGF for a period of time (1∼9 h) before the extr...
<p>(<b>A and B</b>) A431 cells were treated with 50 ng/ml EGF for 3 h and then treated with 5 µg/ml ...
<p>(A) SMMC7721 cells were transfected with HA-TBC1D3, HA-TBC1D3(Δ320–353) and control HA vector, re...
<p>(A) Cells were treated with PBS, DMSO (100 nM), or AG1478 (100 nM) at 37°C for 48 h. The culture ...
<p>(A,C) A-10 cells stably expressing control plasmid, WT or 247R receptors were cultured in the pre...
<p>A. CHO cells stably expressing αPIX<sup>WT</sup> or CAT (control) were transfected with EGFR expr...
<p>(A) Activation of SphK2 in response to RS218 did not differ between HBMEC with and without gefiti...
<p>Undifferentiated K5<sup>+</sup>K19<sup>-</sup> hMECs were starved of serum/growth factors for 48 ...
<p>(<b>A</b>) A431 cells were treated with various concentration of LY294002 as indicated for 1 h an...
<p><b>A</b> Analysis of the total phosphorylation of EGFR. MDA-MB-468 cells were treated with 3 nM, ...